CN105211849A - A kind of health food of prevention and therapy diabetes - Google Patents
A kind of health food of prevention and therapy diabetes Download PDFInfo
- Publication number
- CN105211849A CN105211849A CN201510527922.2A CN201510527922A CN105211849A CN 105211849 A CN105211849 A CN 105211849A CN 201510527922 A CN201510527922 A CN 201510527922A CN 105211849 A CN105211849 A CN 105211849A
- Authority
- CN
- China
- Prior art keywords
- chinese
- fruit
- root
- diabetes
- prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 36
- 235000013402 health food Nutrition 0.000 title claims abstract description 15
- 230000002265 prevention Effects 0.000 title claims abstract description 14
- 238000002560 therapeutic procedure Methods 0.000 title claims abstract description 13
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 241001412627 Adenophora liliifolia Species 0.000 claims abstract description 8
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 8
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 8
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 8
- 244000160089 Crataegus cuneata Species 0.000 claims abstract description 8
- 235000008440 Crataegus cuneata Nutrition 0.000 claims abstract description 8
- 235000014283 Crataegus pinnatifida var major Nutrition 0.000 claims abstract description 8
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 8
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 8
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 8
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 8
- 241000222336 Ganoderma Species 0.000 claims abstract description 8
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract description 8
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 8
- 239000009636 Huang Qi Substances 0.000 claims abstract description 8
- 244000241872 Lycium chinense Species 0.000 claims abstract description 8
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 8
- 244000302512 Momordica charantia Species 0.000 claims abstract description 8
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 8
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 8
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 8
- 240000000249 Morus alba Species 0.000 claims abstract description 8
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 8
- 240000002948 Ophiopogon intermedius Species 0.000 claims abstract description 8
- 235000014676 Phragmites communis Nutrition 0.000 claims abstract description 8
- 244000197580 Poria cocos Species 0.000 claims abstract description 8
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 8
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 8
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 8
- 241000405414 Rehmannia Species 0.000 claims abstract description 8
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 abstract description 24
- 239000008280 blood Substances 0.000 abstract description 18
- 210000004369 blood Anatomy 0.000 abstract description 16
- 230000007812 deficiency Effects 0.000 abstract description 10
- 230000036541 health Effects 0.000 abstract description 6
- 235000008216 herbs Nutrition 0.000 abstract description 5
- 230000035622 drinking Effects 0.000 abstract description 4
- 230000010354 integration Effects 0.000 abstract description 4
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 230000008520 organization Effects 0.000 abstract description 2
- 239000000419 plant extract Substances 0.000 abstract description 2
- 230000000087 stabilizing effect Effects 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000012141 concentrate Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000006378 damage Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 206010022489 Insulin Resistance Diseases 0.000 description 3
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 230000003914 insulin secretion Effects 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- LLJFMFZYVVLQKT-UHFFFAOYSA-N 1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-2-isoquinolinyl)ethyl]phenyl]sulfonylurea Chemical compound C=1C(OC)=CC=C(C(C2=O)(C)C)C=1C(=O)N2CCC(C=C1)=CC=C1S(=O)(=O)NC(=O)NC1CCCCC1 LLJFMFZYVVLQKT-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
- FZNCGRZWXLXZSZ-CIQUZCHMSA-N Voglibose Chemical compound OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O FZNCGRZWXLXZSZ-CIQUZCHMSA-N 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229960004580 glibenclamide Drugs 0.000 description 2
- 229960003468 gliquidone Drugs 0.000 description 2
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011812 mixed powder Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229960001729 voglibose Drugs 0.000 description 2
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000010837 Diabetic eye disease Diseases 0.000 description 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001280 Prediabetic State Diseases 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 229940123464 Thiazolidinedione Drugs 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960002632 acarbose Drugs 0.000 description 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
- 230000001194 anti-hemostatic effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- WIGIZIANZCJQQY-RUCARUNLSA-N glimepiride Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C=C1 WIGIZIANZCJQQY-RUCARUNLSA-N 0.000 description 1
- 229960004346 glimepiride Drugs 0.000 description 1
- ZJJXGWJIGJFDTL-UHFFFAOYSA-N glipizide Chemical compound C1=NC(C)=CN=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZJJXGWJIGJFDTL-UHFFFAOYSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229960003243 phenformin Drugs 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 229960004586 rosiglitazone Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 150000001467 thiazolidinediones Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to a kind of health food of prevention and therapy diabetes, by following raw material by weight ratio make: mulberry leaf 30g, sea-buckthorn 20g, reed rhizome 25g, sealwort 15g, root of kudzu vine 20g, Radix Astragali 15g, dried rhizome of rehmannia 15g, cultivated land 15g, wind-weed 12g, balsam pear 20g, Poria cocos 15g, the root of straight ladybell 15g, the tuber of dwarf lilyturf 15g, fruit of Chinese magnoliavine 10g, cassia seed 15g, large-fruited Chinese hawthorn 10g, glossy ganoderma 20g, coix seed 18g, fruit of Chinese wolfberry 10g, Chinese yam 20g.The all compositions of the present invention all from the plant extract of integration of drinking and medicinal herbs, meet green that the World Health Organization (WHO) advocates, safety take direction, compensate for traditional Chinese medicine and the Western medicine many deficiencies in hypoglycemic, stabilizing blood sugar, control complication.
Description
Technical field
The present invention relates to technical field of health care food, especially relate to a kind of health food of prevention and therapy diabetes.
Background technology
Diabetes have become one of the frequently-occurring disease, common disease of society, and patient populations gets more and more, and patient age is more and more less, falls ill and not easily removes." one day is ill, takes medicine throughout one's life ".Current diabetes essential therapeutic arsenals is exactly based on Chinese medicine and Western medicine.
The maximum feature of diabetes treatment by western medicine is: blood sugar reducing function is obvious, but side effect is large, there is primary to lose efficacy and secondary failure, long-term taking has damage to human organism, especially the impariment of the liver, be impairment of the kidney, there is the long-pending poison reaction of medicine simultaneously, and will strictly control medicine time and whether dosage is correct.
The maximum feature of TCM treatment of diabetes is the clinical manifestation according to patient, first distinguishes its characteristic of disease, then diagnosis and treatment based on an overall analysis of the illness and the patient's condition, integrally-regulated, thus can effectively slow down the process even stoping disease, and toxic and side effect is less.
The traditional Chinese medical science is thought: diabetes are food, strongly fragrant, phlegm, wet, heat, the stasis of blood interweave for suffering from.Its interpretation of the cause, onset and process of an illness develops basic by strongly fragrant, hot, empty, damage four-stage development.Early stage is strongly fragrant based on six, and sick position is many liver, at spleen (stomach); Continue then strongly fragrant heat-transmission of a specified duration, based on liver heat, stomach energy, and lung heat of also can holding concurrently, intestines heat; Scorching both of a specified duration, superheat consuming qi, scorching impairment of yin, yin deficiency affecting yang, all empty to negative and positive of qi and blood eventually; Internal organs are impaired, disease and evil people network, and network damages arteries and veins and damages, and deterioration of a case is numerous.
The sick position of diabetes, at the five internal organs, based on spleen (stomach), liver, kidney, relates to cardiopulmonary; The deficiency of Yin or the deficiency of vital energy are this, and the turbid blood stasis of phlegm is mark, many simulataneous insufficiency and excessive.Initial stage is disorder of emotion, and phlegm turbidity thermal burn is cloudy, real to mark; Then be deficiency of both qi and yin, finally yin-yang deficiency, folder phlegm-turbidity and blood stasis blood of holding concurrently, based on this void.Deficiency of Yin blood vessels run not smooth, the deficiency of vital energy and agitate unable, the turbid retardance of phlegm, blood vessels unfavorable etc. all can to form hemostasis, phlegm is turbid is the pathologic basis that hemostasis is formed, and the two influences each other, hemostasis is carried throughout, it is the pathologic basis that diabetes and complication occur and develop, phlegm-turbidity and blood stasis blood can damage internal organs again, wasting QI-blood, makes pathology intricate.
Modern medicine is thought: diabetes spp whole body chronic metabolic disease, because insulin secretion is absolute or relative deficiency (defect of insulin secretion), and body target tissue or target organ reduce (insulin action defect) β cell to insulin sensitivity and can not make sensitive secretory reaction to change of blood sugar, the glucose of muscle and adipose tissue is taken in and to be reduced and liver glucose exports and increases and formed.
Diabetes are divided into again primary diabetes mellitus and secondary diabetes, and primary diabetes mellitus is divided into again type 1 diabetes and type-II diabetes, and type 1 diabetes is that insulin secretion is definitely not enough, and type-II diabetes (is insufficient insulin companion opposing; Prediabetes, glycosuria stadium and chronic complicating diseases phase is divided into by its natural process.
Its cause of disease source is mainly by inherent cause, immunologic function disorder, mental element, gestation, fat, the factors such as stress reaction act on body and cause hypoinsulinism, insulin resistance etc. and cause sugar, protein, fat, a series of metabolic disorder such as water and eletrolytes and being formed, clinically, take hyperglycaemia as main feature, can diuresis be there is in model case, many drinks, many foods, the performance such as to become thin, i.e. " three-many-one-little " symptom, long-term blood glucose raises can cause retina, kidney, the major vascular such as peripheral nerve or blood vessel, capilary and DPN, the lethal main causes disabled of diabetes.
At present in the oral drugs for the treatment of diabetes, Western medicine mainly contains
1, sulfonylureas, represents medicine: glibenclamide (glibenclamide), lattice row pyrrole are rattled away (Minidiab), gliquidone (Gliquidone), Glimepiride etc.,
2, biguanides, represents medicine: insoral (phenformin) and melbine (melbine)
3, thiazolidinediones, represents medicine: Rosiglitazone, pyrrole put row ketone.
4, α-glucosidase inhibitor, represents medicine: acarbose (visiing Tang Ping) and voglibose (Voglibose).All have a common feature to be exactly that blood sugar reducing function is obvious in these OHAs, but side effect is large, there is primary and lost efficacy and secondary failure, long-term taking has damage to body, especially the impariment of the liver, is impairment of the kidney.There is the long-pending poison reaction of medicine simultaneously.And to strictly control medicine time and whether dosage is correct.
Therefore, Chinese medicine serves huge effect in treating diabetes, and the maximum feature of TCM treatment of diabetes is the main clinical manifestation current according to patient, first distinguish its characteristic of disease, in diagnosis and treatment based on an overall analysis of the illness and the patient's condition, integrally-regulated, thus can effectively slow down the process even stoping disease.Toxic and side effect is less, compensate for Western medicine deficiency, and traditional Chinese medicine day by day demonstrates the advantage of its uniqueness in the treatment of diabetes, contains potentiality greatly.
But Traditional Chinese Medicine medication and operation relative complex, onset slowly, costly, is the maximum drawback of current treatment by Chinese herbs.
Summary of the invention
For above deficiency, the technical problem that the present invention solves is to provide health food of a kind of prevention and therapy diabetes and preparation method thereof, the present invention is according to " NF " " principle of integration of drinking and medicinal herbs ", according to Traditional Chinese medical theory, in conjunction with modern genetics, nutrition, biology and molecular chemistry theory, final integrated we.
The present invention passes through: nourishing cell, strengthening endocrine, enhancing immunity of organism, the strong organ function of help, reinforcement improve microcirculation in human body, accelerate the effects such as body intracellular metabolic, reduce the toxicity of high sugar to cell, reduce the load of B cell, promote that islet function recovers, promote the self-healing ability of diabetic.Meanwhile, carry out integrally-regulated to human body, reduce or block generation and the development of diabetes and complication with this.
Outstanding feature of the present invention: (1) instructions of taking is simple and convenient, rapid-action (twice on the one 3-7 days take effect).(2) applied widely, (the present invention not only has well adjustment blood sugar effect, and have preventive and therapeutic effect to multiple complications such as diabetic eye diseases, high fat of blood, cardiovascular and cerebrovascular diseases), the not long-pending poison of (3) oral safety, is applicable to long-term taking.(4) can not to develop immunity to drugs and secondary failure.
Diabetes, as a kind of chronic disease, medically still belong to the disease of refractory, the prevention that patient self is long-term and take good care of extremely important and crucial.
The object of this invention is to provide a kind of health food of prevention and therapy diabetes, all compositions are all from the plant extract of integration of drinking and medicinal herbs, meet green that the World Health Organization (WHO) advocates, safety take direction, compensate for traditional Chinese medicine and the Western medicine many deficiencies in hypoglycemic, stabilizing blood sugar, control complication.
In order to achieve the above object, the present invention realizes by the following technical solutions:
A health food for prevention and therapy diabetes, by following raw material by weight ratio make: mulberry leaf 20-30g, sea-buckthorn 15-20g, reed rhizome 15-25g, sealwort 10-15g, root of kudzu vine 15-20g, Radix Astragali 10-15g, dried rhizome of rehmannia 10-15g, cultivated land 8-15g, wind-weed 8-12g, balsam pear 15-20g, Poria cocos 10-15g, the root of straight ladybell 10-15g, the tuber of dwarf lilyturf 10-15g, fruit of Chinese magnoliavine 6-10g, cassia seed 8-15g, large-fruited Chinese hawthorn 6-10g, glossy ganoderma 10-20g, coix seed 10-18g, fruit of Chinese wolfberry 6-10g, Chinese yam 15-20g.
A preparation method for the health food of prevention and therapy diabetes, comprises the following steps:
1) by above raw material by weight ratio weigh, with water refluxing extraction 3 times, the extracting liquid filtering obtained, merging filtrate concentrates, and concentrate is dry, obtains powder for subsequent use;
2) by above raw material by weight ratio weigh, extract 2 times with 60-70% alcohol reflux, the extracting liquid filtering obtained, merging filtrate concentrates, and concentrate is dry, obtains powder for subsequent use;
3) by step 1) powder that obtains and step 2) powder that obtains merges and mixes thoroughly and get final product;
4) industry conventional method is adopted, by mixed-powder film-making agent, pill, capsule, granule, oral liquid, health drink, directly oral or go with rice or bread edible.
Choosing and preparation method thereof of described raw material components all performs in strict accordance with " national food safety standard health food " (GB16740-2014) standard-required.
Compared with prior art, the invention has the beneficial effects as follows:
(1) utilize the contained element of plant itself completely, mutually merge and produce effect, dispel turbid Li Mai.And make full use of trace element and the mineral matter of various plants, carry out the necessary nutrient of supplementary diabetic, make human body biochemical reaction energy sufficient, metabolism is accelerated, promotion body metabolism system, the circulatory system recover normal gradually, and QI-blood circulation is smooth and easy, with this, prevent or delay generation and the development of complication, promote the self-healing ability of diabetic.
(2) the present invention, after human intestines and stomach absorbs, enter pathology pancreas islet district and optimum β cell has very strong affinity, can be increased sharply serum insulin content, promote the secreting function of β cell, and improve permeability and the function of motion of cells in vivo film, strengthen the physiological reaction of cell and glucose, become the cellular metabolism energy, thus fall low levels;
(3) Platelet can be reduced, accelerating fibers protein dissolution process, the fibrinous abnormal aggregation of anti-hemostatic tube, improve pancreas physiology microcirculqtory system, repair impaired pancreas, strengthen activity of islet cells, improve sensitiveness and the affinity of acceptor, weaken and progressively insulin resistance in purged body, promote Glycogen synthesis, further balance blood sugar;
(4) take simple, convenient, patient is painful few, go with rice or bread edible or directly oral, one day twice, ante cibum, after meal, on an empty stomach;
(5) all raw materials are chosen according to " integration of drinking and medicinal herbs " catalogue of health ministry regulation completely, are that pure natural plant carries out science extraction completely, and the not long-pending poison of oral safety, is applicable to long-term taking.
Detailed description of the invention
Below in conjunction with specific embodiment, the invention will be further described, but protection domain not thereby limiting the invention.
[embodiment 1]
The food of applicable diabetes patient or a health food, the weight ratio of its raw material components is: mulberry leaf 30g, sea-buckthorn 20g, reed rhizome 25g, sealwort 15g, root of kudzu vine 20g, Radix Astragali 15g, dried rhizome of rehmannia 15g, cultivated land 15g, wind-weed 12g, balsam pear 20g, Poria cocos 15g, the root of straight ladybell 15g, the tuber of dwarf lilyturf 15g, fruit of Chinese magnoliavine 10g, cassia seed 15g, large-fruited Chinese hawthorn 10g, glossy ganoderma 20g, coix seed 18g, fruit of Chinese wolfberry 10g, Chinese yam 20g.
Preparation method is as follows:
1) by above raw material by weight ratio weigh, with water refluxing extraction 3 times, the extracting liquid filtering obtained, merging filtrate concentrates, and concentrate is dry, obtains powder for subsequent use;
2) by above raw material by weight ratio weigh, extract 2 times with 60-70% alcohol reflux, the extracting liquid filtering obtained, merging filtrate concentrates, and concentrate is dry, obtains powder for subsequent use;
3) by step 1) powder that obtains and step 2) powder that obtains merges and mixes and obtain food of the present invention thoroughly;
4) adopt industry conventional method, mixed-powder is made tablet, pill, capsule, granule, oral liquid, health drink.
[embodiment 2]
A health food for prevention and therapy diabetes, by following raw material by weight ratio make: mulberry leaf 20g, sea-buckthorn 15g, reed rhizome 15g, sealwort 10g, root of kudzu vine 15g, Radix Astragali 10g, dried rhizome of rehmannia 10g, cultivated land 8g, wind-weed 8g, balsam pear 15g, Poria cocos 10g, the root of straight ladybell 10g, the tuber of dwarf lilyturf 10g, fruit of Chinese magnoliavine 6g, cassia seed 8g, large-fruited Chinese hawthorn 6g, glossy ganoderma 10g, coix seed 10g, fruit of Chinese wolfberry 6g, Chinese yam 15g.
Preparation method is with embodiment 1.
[embodiment 3]
A health food for prevention and therapy diabetes, by following raw material by weight ratio make: mulberry leaf 30g, sea-buckthorn 20g, reed rhizome 25g, sealwort 15g, root of kudzu vine 20g, Radix Astragali 15g, dried rhizome of rehmannia 15g, cultivated land 15g, wind-weed 12g, balsam pear 20g, Poria cocos 15g, the root of straight ladybell 15g, the tuber of dwarf lilyturf 15g, fruit of Chinese magnoliavine 10g, cassia seed 15g, large-fruited Chinese hawthorn 10g, glossy ganoderma 20g, coix seed 18g, fruit of Chinese wolfberry 10g, Chinese yam 20g.
Preparation method is with embodiment 1.
[embodiment 4]
A health food for prevention and therapy diabetes, by following raw material by weight ratio make: mulberry leaf 25g, sea-buckthorn 18g, reed rhizome 20g, sealwort 12g, root of kudzu vine 18g, Radix Astragali 15g, dried rhizome of rehmannia 10g, cultivated land 10g, wind-weed 8g, balsam pear 16g, Poria cocos 12g, the root of straight ladybell 12g, the tuber of dwarf lilyturf 12g, fruit of Chinese magnoliavine 8g, cassia seed 10g, large-fruited Chinese hawthorn 8g, glossy ganoderma 15g, coix seed 12g, fruit of Chinese wolfberry 8g, Chinese yam 16g.
Preparation method is with embodiment 1.
Claims (2)
1. a health food for prevention and therapy diabetes, is characterized in that, by following raw material by weight ratio make: mulberry leaf 20-30g, sea-buckthorn 15-20g, reed rhizome 15-25g, sealwort 10-15g, root of kudzu vine 15-20g, Radix Astragali 10-15g, dried rhizome of rehmannia 10-15g, cultivated land 8-15g, wind-weed 8-12g, balsam pear 15-20g, Poria cocos 10-15g, the root of straight ladybell 10-15g, the tuber of dwarf lilyturf 10-15g, fruit of Chinese magnoliavine 6-10g, cassia seed 8-15g, large-fruited Chinese hawthorn 6-10g, glossy ganoderma 10-20g, coix seed 10-18g, fruit of Chinese wolfberry 6-10g, Chinese yam 15-20g.
2. the health food of a kind of prevention and therapy diabetes according to claim 1, is characterized in that, preferred weight part ratio of described raw material components is: mulberry leaf 30g, sea-buckthorn 20g, reed rhizome 25g, sealwort 15g, root of kudzu vine 20g, Radix Astragali 15g, dried rhizome of rehmannia 15g, cultivated land 15g, wind-weed 12g, balsam pear 20g, Poria cocos 15g, the root of straight ladybell 15g, the tuber of dwarf lilyturf 15g, fruit of Chinese magnoliavine 10g, cassia seed 15g, large-fruited Chinese hawthorn 10g, glossy ganoderma 20g, coix seed 18g, fruit of Chinese wolfberry 10g, Chinese yam 20g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510527922.2A CN105211849A (en) | 2015-08-24 | 2015-08-24 | A kind of health food of prevention and therapy diabetes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510527922.2A CN105211849A (en) | 2015-08-24 | 2015-08-24 | A kind of health food of prevention and therapy diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105211849A true CN105211849A (en) | 2016-01-06 |
Family
ID=54981462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510527922.2A Pending CN105211849A (en) | 2015-08-24 | 2015-08-24 | A kind of health food of prevention and therapy diabetes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105211849A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105638881A (en) * | 2016-01-22 | 2016-06-08 | 杭州富阳飞博科技有限公司 | Milk product with lactobacilli and preparation technology thereof |
CN105919096A (en) * | 2016-05-16 | 2016-09-07 | 西藏康德生物科技有限公司 | Healthcare food composition and preparation and application thereof |
CN107692187A (en) * | 2017-08-22 | 2018-02-16 | 华加云海健康科技(青岛)有限公司 | One kind improves liver function and reduces postprandial blood sugar ramp-up rate, and gradually reduces the food of postprandial blood sugar |
CN107692222A (en) * | 2017-10-27 | 2018-02-16 | 北京昆达中医医学研究院 | A kind of Traditional Chinese medicine for decreasing blood sugar dietotherapy is for food product |
CN109275681A (en) * | 2018-09-28 | 2019-01-29 | 潘维新 | A kind of functional food suitable for diabetes patient |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101243883A (en) * | 2008-03-27 | 2008-08-20 | 北京惠中铭捷生物科技有限公司 | Health food with function of reducing blood sugar and its preparation |
CN101773624A (en) * | 2010-02-09 | 2010-07-14 | 陈秋生 | Traditional Chinese medicine composition for curing diabetes and preparation method thereof |
CN102652801A (en) * | 2011-03-03 | 2012-09-05 | 陕西诺华生物工程有限公司 | Chinese herbal medicine tea bag for lowering blood sugar and preventing diabetes mellitus complications |
CN103638389A (en) * | 2013-12-24 | 2014-03-19 | 山东省中医药研究院 | Traditional Chinese medicine composition for treating diabetes |
CN103893547A (en) * | 2014-04-09 | 2014-07-02 | 李建明 | Traditional Chinese medicinal composition for treating diabetes mellitus |
-
2015
- 2015-08-24 CN CN201510527922.2A patent/CN105211849A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101243883A (en) * | 2008-03-27 | 2008-08-20 | 北京惠中铭捷生物科技有限公司 | Health food with function of reducing blood sugar and its preparation |
CN101773624A (en) * | 2010-02-09 | 2010-07-14 | 陈秋生 | Traditional Chinese medicine composition for curing diabetes and preparation method thereof |
CN102652801A (en) * | 2011-03-03 | 2012-09-05 | 陕西诺华生物工程有限公司 | Chinese herbal medicine tea bag for lowering blood sugar and preventing diabetes mellitus complications |
CN103638389A (en) * | 2013-12-24 | 2014-03-19 | 山东省中医药研究院 | Traditional Chinese medicine composition for treating diabetes |
CN103893547A (en) * | 2014-04-09 | 2014-07-02 | 李建明 | Traditional Chinese medicinal composition for treating diabetes mellitus |
Non-Patent Citations (1)
Title |
---|
陈艳: "《糖尿病患者用药知识》", 30 June 2003 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105638881A (en) * | 2016-01-22 | 2016-06-08 | 杭州富阳飞博科技有限公司 | Milk product with lactobacilli and preparation technology thereof |
CN105919096A (en) * | 2016-05-16 | 2016-09-07 | 西藏康德生物科技有限公司 | Healthcare food composition and preparation and application thereof |
CN105919096B (en) * | 2016-05-16 | 2020-05-22 | 西藏海容唐果健康产业有限公司 | Health food composition, preparation and application thereof |
CN107692187A (en) * | 2017-08-22 | 2018-02-16 | 华加云海健康科技(青岛)有限公司 | One kind improves liver function and reduces postprandial blood sugar ramp-up rate, and gradually reduces the food of postprandial blood sugar |
CN107692222A (en) * | 2017-10-27 | 2018-02-16 | 北京昆达中医医学研究院 | A kind of Traditional Chinese medicine for decreasing blood sugar dietotherapy is for food product |
CN109275681A (en) * | 2018-09-28 | 2019-01-29 | 潘维新 | A kind of functional food suitable for diabetes patient |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102669667B (en) | Health food with dual functions of protecting liver and adjusting blood fat and preparation method thereof | |
CN105211849A (en) | A kind of health food of prevention and therapy diabetes | |
CN100374140C (en) | Health-care for diabetes | |
CN102150692B (en) | Biscuit with function of curing diabetes and preparation method thereof | |
CN104645132B (en) | A kind of Chinese medicine composition that treating diabetic nephropathy, preparation method, Chinese medicine preparation and application | |
CN105727015A (en) | Composition for regulating blood lipid and blood pressure and preparation method thereof | |
CN102113651B (en) | Steamed bread for being eaten by patients who suffer from diabetes and preparation method thereof | |
CN102113534A (en) | Moon cake with function of treating diabetes and preparation method thereof | |
CN109771578A (en) | The composition for preventing and treating diabetes and complication | |
CN102652561A (en) | Vegetable protein food for treating micro-disease or assisting medicament in rehabilitating sick body and production method thereof | |
CN102150844A (en) | Dried noodles with function of treating diabetes and preparation method of dried noodles | |
CN109498731A (en) | A kind of tonifying speen and tonifying kidney tune sugar-pill and preparation method thereof for treating diabetes B Pishenqixu syndrome | |
CN102113668B (en) | Quick-frozen boiled dumplings applicable to diabetes and preparation method thereof | |
CN102150779B (en) | Health food for regulating and stabilizing blood sugar and preparation method thereof | |
CN104367753B (en) | A kind of Chinese medicine composition for treating diabetes B | |
CN103919022A (en) | Health-care steamed buns for preventing and treating hyperglycemia | |
CN103656196B (en) | Chinese medicine composition and the preparation method of the pruitus that treatment diabetes cause | |
CN104095930B (en) | A kind of Chinese medicine for the treatment of gastrorrhagia | |
CN103341073B (en) | Traditional Chinese medicine preparation for treatment of diabetes and preparation method thereof | |
CN102114206A (en) | Powder capable of restoring function of pancreatic islet and preparation method thereof | |
CN102119732B (en) | Milk powder with function of treating diabetes and preparation method thereof | |
CN103845581A (en) | Natural green composition and application thereof to preventing and treating diabetes | |
CN104524003A (en) | Traditional Chinese medicine composition with golden camellia and radix pueraiae | |
CN110368469A (en) | Join glue stilbene particle drink | |
CN104740428B (en) | A kind of compound tonifying blood containing red skin of peanut pharmaceutical preparation and its application and detection method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160106 |